Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12FJ4 | ISIN: AU000000PAR5 | Ticker-Symbol: P86
Frankfurt
06.06.25 | 15:29
0,156 Euro
-4,88 % -0,008
Branche
Pharma
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
PARADIGM BIOPHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
PARADIGM BIOPHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur PARADIGM BIOPHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoPARADIGM BIOPHARMACEUTICALS LIMITED: Phase 3 Knee OA Trial Begins, Site Live, Patient Consented-
29.05.PARADIGM BIOPHARMACEUTICALS LIMITED: Results of Meeting-
14.05.PARADIGM BIOPHARMACEUTICALS LIMITED: PAR Receives US Ethics Approval for Phase 3-
29.04.PARADIGM BIOPHARMACEUTICALS LIMITED: Notice of General Meeting/Proxy Form-
29.04.PARADIGM BIOPHARMACEUTICALS LIMITED: March 2025 Quarterly Activities Report & Appendix 4C-
PARADIGM BIOPHARMACEUTICALS Aktie jetzt für 0€ handeln
18.03.PARADIGM BIOPHARMACEUTICALS LIMITED: Paradigm to present at NWR Healthcare Conference3
14.03.PARADIGM BIOPHARMACEUTICALS LIMITED: Application for quotation of securities - PAR1
07.03.PARADIGM BIOPHARMACEUTICALS LIMITED: S&P DJI Announces March 2025 Quarterly Rebalance-
26.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Appendix 4D and Half Year Report-
23.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Paradigm Secures Ethics Approval for Phase 3 Trial-
14.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Change of Director's Interest Notice1
14.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Change of Director's Interest Notice1
09.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Listing of Options - Top 20 Holders and Distribution Reports-
09.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Application for quotation of securities - PAR-
02.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Cancel - Proposed issue of securities - PAR-
02.02.PARADIGM BIOPHARMACEUTICALS LIMITED: Proposed issue of securities - PAR-
31.01.PARADIGM BIOPHARMACEUTICALS LIMITED: Proposed issue of securities - PAR1
31.01.PARADIGM BIOPHARMACEUTICALS LIMITED: Loyalty and Piggyback Options Program1
30.01.PARADIGM BIOPHARMACEUTICALS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report1
29.01.PARADIGM BIOPHARMACEUTICALS LIMITED: Application for quotation of securities - PAR2
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1